Open | - |
Close | - |
Volume / Avg. | 0 / 16.640K |
Day Range | - - - |
52 Wk Range | 1.150 - 2.980 |
Market Cap | $4.560M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.27% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Artelo Biosciences (NASDAQ: ARTL) through any online brokerage.
Other companies in Artelo Biosciences’s space includes: Cingulate (NASDAQ:CING), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
The latest price target for Artelo Biosciences (NASDAQ: ARTL) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a price target for 5.00 expecting ARTL to rise to within 12 months (a possible 249.65% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Artelo Biosciences (NASDAQ: ARTL) is $1.43 last updated March 18, 2024 at 7:24 PM EDT.
There are no upcoming dividends for Artelo Biosciences.
Artelo Biosciences’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Artelo Biosciences.
Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.